Lilly's Tirzepatide - Search News

Cipla, Eli Lilly and India

Stocktwits on MSN · 2d

Cipla Shares Fall To Biggest Intra-day Lows In Six Months Despite Eli Lilly Deal For Diabetes Drug

Cipla-Eli Lilly partner to distribute Tirzepatide under the Yurpeak brand in India ・Tirzepatide is used to manage type 2 diabetes and chronic weight issues in adults ・The stock has outperformed the broader pharma index YTD Shares of Cipla fell 3.

Continue reading

· 3d · on MSN

Eli Lilly gives Cipla license to sell weight-loss drug Tirzepatide in India

The Pharma Letter · 1d

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

11don MSN

1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today

Eli Lilly (NYSE: LLY) has been one of the best-performing healthcare giants over the past decade. It now stands as the ...

2d

Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings

LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results